These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8782981)

  • 1. Central nervous system cell transplantation: a novel therapy for storage diseases?
    Snyder EY; Wolfe JH
    Curr Opin Neurol; 1996 Apr; 9(2):126-36. PubMed ID: 8782981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions.
    Snyder EY; Macklis JD
    Clin Neurosci; 1995-1996; 3(5):310-6. PubMed ID: 8914798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy in neurology.
    Snyder EY; Fisher LJ
    Curr Opin Pediatr; 1996 Dec; 8(6):558-68. PubMed ID: 9018439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.
    Zlokovic BV; Apuzzo ML
    Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain.
    Snyder EY; Taylor RM; Wolfe JH
    Nature; 1995 Mar; 374(6520):367-70. PubMed ID: 7885477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural precursor cells: applications for the study and repair of the central nervous system.
    Fisher LJ
    Neurobiol Dis; 1997; 4(1):1-22. PubMed ID: 9258907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse.
    Meng XL; Shen JS; Ohashi T; Maeda H; Kim SU; Eto Y
    J Neurosci Res; 2003 Oct; 74(2):266-77. PubMed ID: 14515356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular restorative neurosurgery: a novel concept for molecular and cellular therapy of the nervous system.
    Amar AP; Zlokovic BV; Apuzzo ML
    Neurosurgery; 2003 Feb; 52(2):402-12; discussion 412-3. PubMed ID: 12535371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immortalized neural progenitor cells for CNS gene transfer and repair.
    Martínez-Serrano A; Björklund A
    Trends Neurosci; 1997 Nov; 20(11):530-8. PubMed ID: 9364668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term expression of beta-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system.
    Buchet D; Serguera C; Zennou V; Charneau P; Mallet J
    Mol Cell Neurosci; 2002 Mar; 19(3):389-401. PubMed ID: 11906211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes.
    Flax JD; Aurora S; Yang C; Simonin C; Wills AM; Billinghurst LL; Jendoubi M; Sidman RL; Wolfe JH; Kim SU; Snyder EY
    Nat Biotechnol; 1998 Nov; 16(11):1033-9. PubMed ID: 9831031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stem cell and repair of injury in central nervous system].
    Wang H; Wang X; Zheng R
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Dec; 23(6):1359-62. PubMed ID: 17228744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of neural stem cells.
    Martino G; Pluchino S
    Nat Rev Neurosci; 2006 May; 7(5):395-406. PubMed ID: 16760919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice.
    Skorupa AF; Fisher KJ; Wilson JM; Parente MK; Wolfe JH
    Exp Neurol; 1999 Nov; 160(1):17-27. PubMed ID: 10630187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of neural "stem-like" cells for gene therapy and repair of the degenerating central nervous system.
    Snyder EY; Park KI; Flax JD; Liu S; Rosario CM; Yandava BD; Aurora S
    Adv Neurol; 1997; 72():121-32. PubMed ID: 8993691
    [No Abstract]   [Full Text] [Related]  

  • 16. Stem and progenitor cell-based therapy of the human central nervous system.
    Goldman S
    Nat Biotechnol; 2005 Jul; 23(7):862-71. PubMed ID: 16003375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors.
    Corti O; Sabaté O; Horellou P; Colin P; Dumas S; Buchet D; Buc-Caron MH; Mallet J
    Nat Biotechnol; 1999 Apr; 17(4):349-54. PubMed ID: 10207882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurogenesis as a therapeutic strategy to regenerate central nervous system].
    Arias-Carrión O; Drucker-Colín R
    Rev Neurol; 2007 Dec 16-31; 45(12):739-45. PubMed ID: 18075989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection.
    De Feo D; Merlini A; Laterza C; Martino G
    Curr Opin Neurol; 2012 Jun; 25(3):322-33. PubMed ID: 22547103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural stem cells: on where they hide, in which disguise, and how we may lure them out.
    Berninger B; Hack MA; Götz M
    Handb Exp Pharmacol; 2006; (174):319-60. PubMed ID: 16370334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.